98 related articles for article (PubMed ID: 23670122)
1. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of zo-1 and id4 gene abnormal methylation in multiple myeloma].
Kang HY; Wang XR; Wang LL; Wang C; Cen J; Gao L; Liu Y; Li YH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1192-7. PubMed ID: 21129259
[TBL] [Abstract][Full Text] [Related]
3. [ZO-1 gene methylation status and its clinical significance in children with non-Hodgkin lymphoma].
Diao YQ; Qu F; Yang MJ; Meng JH; Zhu XL; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):619-23. PubMed ID: 24927439
[TBL] [Abstract][Full Text] [Related]
4. [Significance of id4 gene promoter methylation detection in lymphoma].
Zhao Y; Jing Y; Bo J; Wang SH; Wang QS; Li HH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):322-4. PubMed ID: 18426657
[TBL] [Abstract][Full Text] [Related]
5. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
Wang H; Wang XQ; Xu XP; Lin GW
Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
[TBL] [Abstract][Full Text] [Related]
6. [ID4 promoter methylation in acute myeloid leukemia].
Xu RR; Liu F; Cui X; Zhang XW; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):582-4. PubMed ID: 21729527
[TBL] [Abstract][Full Text] [Related]
7. [Methylation status of id4 gene promoter in patients with chronic myeloid leukemia].
Wang XR; Kang HY; Cen J; Li YH; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1402-4. PubMed ID: 21176338
[TBL] [Abstract][Full Text] [Related]
8. [The methylation pattern and clinical significance of Zonula occludens-1 gene promoter in acute leukemia].
Wang C; Wang GJ; Tan YH; Li W; Liu CH; Yu L
Zhonghua Nei Ke Za Zhi; 2008 Feb; 47(2):111-3. PubMed ID: 18683795
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.
Martini M; Cenci T; D'Alessandris GQ; Cesarini V; Cocomazzi A; Ricci-Vitiani L; De Maria R; Pallini R; Larocca LM
Cancer; 2013 Mar; 119(5):1004-12. PubMed ID: 23132729
[TBL] [Abstract][Full Text] [Related]
10. [Methylation of Id4 gene promoter in 4 malignant hematopoietic cell lines].
Zhao Y; Wang QS; Li HH; Jing Y; Bo J; Wang SH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1418-20. PubMed ID: 19099656
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
[TBL] [Abstract][Full Text] [Related]
12. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary study on Id4 as a reporter for all patients before relapse].
Zhao Y; Li HH; Dou LP; Jing Y; Wang QS; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):990-2. PubMed ID: 18928580
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study on difference of Id4 gene methylation in various types of myelodysplastic syndromes].
Zhao Y; Bo J; Dou LP; Jing Y; Wang SH; Wang QS; Li HH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):618-20. PubMed ID: 19549375
[TBL] [Abstract][Full Text] [Related]
15. [The significance of DNA-binding inhibitor 4 promoter methylation status in acute leukemia].
Zhao Y; Yu L; Wang QS; Li HH; Bo J; Dou LP
Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):576-8. PubMed ID: 17074115
[TBL] [Abstract][Full Text] [Related]
16. [Study on the correlation between Chinese medical syndrome types and ID4 gene promoter methylation in human acute myeloid leukemia].
Liu F; Xu RR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):471-3. PubMed ID: 22803425
[TBL] [Abstract][Full Text] [Related]
17. Role of heteroplasmic mutations in the mitochondrial genome and the ID4 gene promoter methylation region in the pathogenesis of chronic aplastic anemia in patients suffering from Kidney yin deficiency.
Cui X; Wang JY; Liu K; Cui SY; Zhang J; Luo YQ; Wang X
Chin J Integr Med; 2016 Jun; 22(6):412-9. PubMed ID: 25920536
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of ID4 methylation detection by quantitative methylation-specific PCR in acute leukemia].
Liu Y; Zhong WW; Kang HY; Wang LL; Lu XC; Yu L; Zhu HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):675-80. PubMed ID: 24989275
[TBL] [Abstract][Full Text] [Related]
19. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
